Meitheal Pharmaceuticals Inc: Drug Recall

Recall #D-0801-2021 · 09/03/2021

Class III: Low Risk

Recall Details

Recall Number: D-0801-2021
Classification: Class III
Product Type: Drug
Recalling Firm: Meitheal Pharmaceuticals Inc
Status: Terminated
Date Initiated: 09/03/2021
Location: Chicago, IL, United States
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 1,160 ten-pack cartons

Reason for Recall

Failed Impurities/Degradation Specifications

Product Description

Glycopyrrolate Injection, USP 4mg per 20mL, 20 mL Multi-Dose Vials, Rx only, Mfd for Meitheal Pharmaceuticals, Chicago, IL 60631. NDC 71288-408-21

Distribution Pattern

Nationwide within the USA and India

Other Recalls by Meitheal Pharmaceuticals Inc

Class I: Dangerous 01/27/2021

Labeling: Label mix-up: Carton of Cisatracurium Besylate Injection, USP was observed to contain ten vials mislabeled as Phenylephrine Hydrochloride Injection, USP, but confirmed to contain Cisatracurium

View all recalls by Meitheal Pharmaceuticals Inc →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.